UNSPSC 51373415: Brompheniramine/codeine/guaifenesin/phenylephrine/phenylpropanol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373415 Brompheniramine/codeine/guaifenesin/phenylephrine/phenylpropanol, a Commodity code, encompasses pharmaceutical preparations and controlled-substance medications procured by state and local health and corrections agencies to support medically necessary treatment for incarcerated populations and community health initiatives. State corrections departments and county health authorities are the primary issuing bodies under this code, purchasing both compounded parenteral solutions (total parenteral nutrition bags and intravenous preparations) and over-the-counter pharmaceutical products such as naloxone and drug deactivation systems. Recent solicitations reflect a mix of specialized clinical services — including TPN and PPN preparation, IV solution delivery with rapid turnaround requirements (24 hours for PN bags, 8 hours for other parenteral products), and staff qualifications in patient lab monitoring and PN formulation adjustment — alongside broader pharmaceutical commodity procurement supporting public health and harm-reduction missions.

The Washington State Department of Corrections and Seminole County, Florida represent the recent issuing bodies on record. The Washington DOC solicitation (RFQQK13020, RFQ posted September 8, 2026, due October 7, 2026) seeks parenteral products and services across eight facilities in three regions, with contract awards anticipated to multiple vendors per region through June 30, 2030; the solicitation emphasizes SBE, MBE, WBE, and VBE participation with state-mandated set-asides and subcontractor inclusion requirements. The Seminole County opportunity (IFB60459723LAS, posted June 30, 2026) procures 1,900 units of naloxone and 800 drug deactivation systems annually for delivery to the county community health building, with a two-year initial term and one-year renewal option. Washington and Florida represent the most recent geographic activity on this code; no other states appear in the recent opportunity block.